Furthermore, BAFF enhanced the activation of B cell IFN-1 signaling by inhibiting the expression of cytokine signal transduction inhibitor 3, which is involved in the occurrence and development of SLE. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.